| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 10 | 46.419 | 178.364 | 223.569 | 274.265 | 337.405 | 333.727 |
| Total Income - EUR | - | - | - | 10 | 46.419 | 183.017 | 224.025 | 274.266 | 337.406 | 333.731 |
| Total Expenses - EUR | - | - | - | 562 | 47.799 | 153.144 | 180.840 | 237.401 | 276.216 | 321.344 |
| Gross Profit/Loss - EUR | - | - | - | -552 | -1.380 | 29.873 | 43.185 | 36.865 | 61.190 | 12.387 |
| Net Profit/Loss - EUR | - | - | - | -552 | -1.844 | 28.089 | 40.950 | 34.122 | 57.815 | 2.375 |
| Employees | - | - | - | 0 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Biofarmex Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 795 | 646 | 501 | 371 | 240 | 10.393 |
| Current Assets | - | - | - | 713 | 13.830 | 50.111 | 98.272 | 267.535 | 211.794 | 229.482 |
| Inventories | - | - | - | 102 | 11.804 | 42.774 | 83.103 | 191.666 | 179.341 | 145.031 |
| Receivables | - | - | - | 0 | 1.027 | 4.477 | 3.103 | 17.712 | 21.065 | 75.859 |
| Cash | - | - | - | 611 | 999 | 2.860 | 12.066 | 58.157 | 11.388 | 8.593 |
| Shareholders Funds | - | - | - | -509 | -2.343 | 25.790 | 66.168 | 100.496 | 158.007 | 159.499 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 1.222 | 16.968 | 24.967 | 32.605 | 167.411 | 54.026 | 80.376 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Biofarmex Bio S.r.l.